Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke.

Lemaitre RN, Rice K, Marciante K, Bis JC, Lumley TS, Wiggins KL, Smith NL, Heckbert SR, Psaty BM.

Atherosclerosis. 2009 Jun;204(2):e58-63. doi: 10.1016/j.atherosclerosis.2008.10.011. Epub 2008 Nov 1.

2.

Interactions among Variants in Eicosanoid Genes Increase Risk of Atherothrombotic Stroke in Chinese Populations.

Yi X, Lin J, Wang C, Huang R, Liu Y.

J Stroke Cerebrovasc Dis. 2017 Aug;26(8):1773-1780. doi: 10.1016/j.jstrokecerebrovasdis.2017.04.005. Epub 2017 May 3.

PMID:
28478978
3.

Common polymorphisms in the prostaglandin pathway genes and their association with breast cancer susceptibility and survival.

Abraham JE, Harrington P, Driver KE, Tyrer J, Easton DF, Dunning AM, Pharoah PD.

Clin Cancer Res. 2009 Mar 15;15(6):2181-91. doi: 10.1158/1078-0432.CCR-08-0716. Epub 2009 Mar 10.

4.

Variants in COX-2, PTGIS, and TBXAS1 Are Associated with Carotid Artery or Intracranial Arterial Stenosis and Neurologic Deterioration in Ischemic Stroke Patients.

Yi X, Ming B, Wang C, Chen H, Ma C.

J Stroke Cerebrovasc Dis. 2017 May;26(5):1128-1135. doi: 10.1016/j.jstrokecerebrovasdis.2016.12.032. Epub 2017 Jan 17.

PMID:
28108096
5.

A Promoter polymorphism (rs17222919, -1316T/G) of ALOX5AP is associated with intracerebral hemorrhage in Korean population.

Kim DH, Ahn WY, Kim DK, Choe BK, Kim SK, Jo DJ, Kim JY, Chung JH, Jeong YS, Yun DH, Yoo SD, Kim HS, Baik HH.

Prostaglandins Leukot Essent Fatty Acids. 2011 Sep-Oct;85(3-4):115-20. doi: 10.1016/j.plefa.2011.07.004. Epub 2011 Aug 3.

PMID:
21816595
6.

Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study.

Lee CR, North KE, Bray MS, Couper DJ, Heiss G, Zeldin DC.

Clin Pharmacol Ther. 2008 Jan;83(1):52-60. Epub 2007 May 9.

7.

Genetic variants of PTGS2, TXA2R and TXAS1 are associated with carotid plaque vulnerability, platelet activation and TXA2 levels in ischemic stroke patients.

Yi X, Lin J, Luo H, Wang C, Liu Y.

PLoS One. 2017 Jul 12;12(7):e0180704. doi: 10.1371/journal.pone.0180704. eCollection 2017.

8.
9.

Association of COX-2 rs20417 with aspirin resistance.

Sharma V, Kaul S, Al-Hazzani A, Alshatwi AA, Jyothy A, Munshi A.

J Thromb Thrombolysis. 2013 Jan;35(1):95-9. doi: 10.1007/s11239-012-0777-8.

PMID:
22763923
10.

Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke.

Marciante KD, Totah RA, Heckbert SR, Smith NL, Lemaitre RN, Lumley T, Rice KM, Hindorff LA, Bis JC, Hartman B, Psaty BM.

Pharmacogenet Genomics. 2008 Jun;18(6):535-43. doi: 10.1097/FPC.0b013e3282fd1287.

PMID:
18496133
12.

Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke.

Kaplan RC, Smith NL, Zucker S, Heckbert SR, Rice K, Psaty BM.

Atherosclerosis. 2008 Nov;201(1):130-7. doi: 10.1016/j.atherosclerosis.2008.01.003. Epub 2008 Mar 14.

13.

Genetic polymorphisms of ALOX5AP and CYP3A5 increase susceptibility to ischemic stroke and are associated with atherothrombotic events in stroke patients.

Yi X, Zhang B, Wang C, Liao D, Lin J, Chi L.

J Stroke Cerebrovasc Dis. 2015 Mar;24(3):521-9. doi: 10.1016/j.jstrokecerebrovasdis.2014.09.035. Epub 2014 Dec 19.

PMID:
25534367
14.

Association of cyclooxygenase-2 genetic variant with cardiovascular disease.

Ross S, Eikelboom J, Anand SS, Eriksson N, Gerstein HC, Mehta S, Connolly SJ, Rose L, Ridker PM, Wallentin L, Chasman DI, Yusuf S, Paré G.

Eur Heart J. 2014 Sep 1;35(33):2242-8a. doi: 10.1093/eurheartj/ehu168. Epub 2014 May 5.

15.

Impact of COX-2 rs5275 and rs20417 and GPIIIa rs5918 polymorphisms on 90-day ischemic stroke functional outcome: a novel finding.

Maguire J, Thakkinstian A, Levi C, Lincz L, Bisset L, Sturm J, Scott R, Whyte S, Attia J.

J Stroke Cerebrovasc Dis. 2011 Mar-Apr;20(2):134-44. doi: 10.1016/j.jstrokecerebrovasdis.2009.10.011. Epub 2010 May 15.

PMID:
20472470
16.

[Study on the association of cyclooxygenase-2 -765g>C and prostacyclin synthase C1117A polymorphisms and the risk of myocardial infarction in Uigur population of Xinjiang, China].

Xie X, Ma YT, Fu ZY, Yang YN, Wang YH, Chen BD, Liu F.

Zhonghua Liu Xing Bing Xue Za Zhi. 2008 Jun;29(6):598-603. Chinese.

PMID:
19040046
17.

Genetic variation in the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) is associated with myocardial infarction in the German population.

Linsel-Nitschke P, Götz A, Medack A, König IR, Bruse P, Lieb W, Mayer B, Stark K, Hengstenberg C, Fischer M, Baessler A, Ziegler A, Schunkert H, Erdmann J.

Clin Sci (Lond). 2008 Nov;115(10):309-15. doi: 10.1042/CS20070468.

PMID:
18318662
18.

Microsomal prostaglandin E2 synthase-1 deletion leads to adverse left ventricular remodeling after myocardial infarction.

Degousee N, Fazel S, Angoulvant D, Stefanski E, Pawelzik SC, Korotkova M, Arab S, Liu P, Lindsay TF, Zhuo S, Butany J, Li RK, Audoly L, Schmidt R, Angioni C, Geisslinger G, Jakobsson PJ, Rubin BB.

Circulation. 2008 Apr 1;117(13):1701-10. doi: 10.1161/CIRCULATIONAHA.107.749739. Epub 2008 Mar 17.

PMID:
18347209
19.

Association of polymorphisms of PTGS2 and CYP8A1 with myocardial infarction.

Xie X, Ma YT, Fu ZY, Yang YN, Ma X, Chen BD, Wang YH, Liu F.

Clin Chem Lab Med. 2009;47(3):347-52. doi: 10.1515/CCLM.2009.078.

PMID:
19327107
20.

Genetic variants in the promoter region of the ALOX5AP gene and susceptibility of ischemic stroke.

Ji R, Jia J, Ma X, Wu J, Zhang Y, Xu L.

Cerebrovasc Dis. 2011;32(3):261-8. doi: 10.1159/000330341. Epub 2011 Aug 31.

PMID:
21893978

Supplemental Content

Support Center